Tremelimumab
Drug timelines are a Plus or Pro feature.
153 regulatory and trial events tracked for Tremelimumab, covering 2012-07-25 to 2026-08-05. Get the full timeline:
Most recent: Clinical Trial Results: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]